Prot # Amorcyte Study-002: A Prospective Randomized Double Blinded Placebo Controlled Phase II Trial of Intra-coronary Infusion of AMR-001, a Bone Marrow Derived Autologous CD34+ Selected Cell Product, in Patients with Acute Myocardial Infarction

Project: Research project

Project Details

StatusFinished
Effective start/end date5/1/12 → 5/1/18

Funding

  • Clinipace, Inc. (Amorcyte Study-002)
  • Amorcyte, LLC (Amorcyte Study-002)